Friday, 25 September 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 4, 2026

CBRE Group Insiders Sold US$3.3m Of Shares Suggesting Hesitancy

View original at finance.yahoo.com
CBRE Group Insiders Sold US$3.3m Of Shares Suggesting Hesitancy In the last year, many CBRE Group, Inc. (NYSE:CBRE) insiders sold a substantial stake in the company which may have sparked shareholders' attention…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations

    60% confidence

  • We would consider it foolish to ignore insider transactions altogether

    60% confidence

  • Significant insider selling over the last three months makes us a bit cautious, but it's not the be all and end all

    60% confidence

  • We generally don't like to see insider selling, but the lower the sale price, the more it concerns us

    60% confidence

  • When multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag

    60% confidence

  • We usually like to see fairly high levels of insider ownership

    60% confidence

  • Significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders

    60% confidence

  • The big sale took place at around the current price, so it's not too bad (but it's still not a positive)

    60% confidence

  • AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com
CBRE Group Insiders Sold US$3.3m Of Shares Suggesting Hesitancy — Source | Via News | ViaNews EU